Taken together, the evidence suggests that the KMT2A mutations observed herein might play roles in acquisition of radioresistance by tumor cells through loss-of-function of KMT2A, which contributes to suppression of TP53 and other tumor suppressor genes, transcription of which is regulated by methylation on H3K4. Here, KMT2A is linked to neoplasm.